Akebia Therapeutics
AKBA
AKBA
75 hedge funds and large institutions have $30.9M invested in Akebia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 32 reducing their positions, and 23 closing their positions.
Holders
75
Holders Change
-15
Holders Change %
-16.67%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
7
Reduced
32
Closed
23
Calls
$400K
Puts
$39K
Net Calls
+$361K
Net Calls Change
+$116K
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$775K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.48M |
3 |
3
BlackRock
New York
|
$1.69M |
4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$589K |
5 |
5
Goldman Sachs
New York
|
$8.84K |